Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 14.3%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 42.9%Moderate 3 · 42.9%High 0 · 0%

Monthly pulsed high‐dose dexamethasone vs prednisolone

Change in grip strength · patients with chronic inflammatory demyelinating polyradiculoneuropathy

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 38 participants
Moderate

Monthly pulsed high‐dose dexamethasone vs prednisolone

Sleeplessness · patients with chronic inflammatory demyelinating polyradiculoneuropathy

Monthly pulsed high‐dose dexamethasone may leads to lower sleeplessness compared with oral prednisolone (low certainty).

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
RR 0.44
1 study · 40 participants
Low

Monthly pulsed high‐dose dexamethasone vs prednisolone

Moon facies · patients with chronic inflammatory demyelinating polyradiculoneuropathy

Monthly pulsed high‐dose dexamethasone probably leads to lower moon facies compared with oral prednisolone (moderate certainty).

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
RR 0.48
1 study · 40 participants
Moderate

Monthly pulsed high‐dose dexamethasone vs prednisolone

Change in disability after one year · patients with chronic inflammatory demyelinating polyradiculoneuropathy

The review found no eligible studies for this question.

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Monthly pulsed high‐dose dexamethasone vs prednisolone

Remission · patients with chronic inflammatory demyelinating polyradiculoneuropathy

Monthly pulsed high‐dose dexamethasone probably leads to higher remission at 12 months compared with oral prednisolone (moderate certainty).

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
RR 1.11
1 study · 40 participants
Moderate

Monthly pulsed high‐dose dexamethasone vs prednisolone

≥ 1 point improvement on INCAT disability score at 12 months · patients with chronic inflammatory demyelinating polyradiculoneuropathy

Monthly pulsed high‐dose dexamethasone may leads to higher ≥ 1 point improvement on INCAT disability score at 12 months compared with oral prednisolone (low certainty).

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
RR 1.24
1 study · 40 participants
Low

Monthly pulsed high‐dose dexamethasone vs prednisolone

Change in MRC sum score · patients with chronic inflammatory demyelinating polyradiculoneuropathy

1 finding from 1 review

Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Low